[Analysis of epidemiologic risk factors for endometrial cancer]. / Analiza czynników epidemiologicznych u chorych z rakiem blony sluzowej trzonu macicy leczonych w Wielkopolskim Centrum Onkologii.

UNLABELLED: The aim of this study was an analyse of several risk factors for women with endometrial cancer and their influence on overall survival. MATERIALS AND METHODS: A retrospective analysis covered 160 women treated with the primary surgery and adjuvant radiotherapy because of endometrial cancer. Age, lifestyle, age of menarche and menopause, parity, body size, hypertension and diabetes mellitus were determined. RESULTS: The 5-year survival rate were: 87% for the women younger then 60 and 70% for the older ones (p = 0.0026), 81% for the city women and 73% for the country women (p = 0.2034), 91% for the educated women and 70% for the women with elementary education (p = 0.0102), 85% for 1-2 x parous women and 65% for nulliparous (p = 0.0433), 79% for women without miscarriage and 63% for women with 2 or more miscarriages (p = 0.3265), 82% for women with menarche above age of 15 and 66% with menarche under age of 13 (p = 0.1989), 82% for women without obesity, diabetes, hypertension and 72% for women with hypertension, 64% with obesity, 50% for women with all analysed diseases (p = 0.0104). CONCLUSION: An analyse show that age, lifestyle, parity, body size and hypertension modify the overall survival of women with endometrial cancer.

[Intracavitary brachytherapy method using after-loading for treatment of women with endometrial uterine neoplasm]. / Metoda brachyterapii dojamowej technika after-loading w leczeniu kobiet z rakiem blony sluzowej macicy.

We would like to introduce intracavitary brachytherapy using double rod-shaped applicators. The women who are treated with this method are evaluated in III FIGO stage and the patients in stage I and II who could not undergo the operation. This method allows to distribute equally the dose in whole uterus, insertion of the applicators is not difficult. The brachytherapy treatment is well tolerated.

[Evaluation of SCC antigen in patients with advanced cervix cancer treated with radiation]. / Ocena antygenu SCC u chorych na zaawansowanego raka szyjki macicy, leczonych promieniami.

The TA-4 antigen was isolated and described in 1977 by Kato and Torigoe. The antigen called SCC-squamous cell carcinoma is subfraction TA-4 isolated of liver metastases from cervix uteri. The cut-off limits for SCC-antigen is counted as 1.5-2.5 ng/ml. The level of SCC-antigen was determined in the serum of 41 women with advanced cervix uteri cancer-IIIB and IV FIGO stage. The value of SCC-antigen was evaluated twice: before and after the treatment. The increasing of SCC-level was observed in the serum of 80% women. The conclusion are: There was the lowering of SCC-antigen value in patients after the irradiation. In cases of patients who still had high SCC-antigen level after the treatment and it exceeded 8 ng/ml., progression of cancer also was found. The progression of cancer after the treatment was found in women with pretreatment level of SCC-antigen higher than 30 ng/ml.